These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 38555050

  • 1. Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus.
    Chang LH, Chang TT, Chu CH, Huang CC, Lin LY.
    Clin Chim Acta; 2024 May 15; 558():117880. PubMed ID: 38555050
    [Abstract] [Full Text] [Related]

  • 2. Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death.
    Martin WP, Tuohy C, Doody A, Jackson S, Canavan RJ, Slattery D, Twomey PJ, McKenna MJ, le Roux CW, Docherty NG.
    Sci Rep; 2020 Sep 09; 10(1):14852. PubMed ID: 32908199
    [Abstract] [Full Text] [Related]

  • 3. High Baseline Levels of Tumor Necrosis Factor Receptor 1 Are Associated With Progression of Kidney Disease in Indigenous Australians With Diabetes: The eGFR Follow-up Study.
    Barr ELM, Barzi F, Hughes JT, Jerums G, Hoy WE, O'Dea K, Jones GRD, Lawton PD, Brown ADH, Thomas M, Ekinci EI, Sinha A, Cass A, MacIsaac RJ, Maple-Brown LJ.
    Diabetes Care; 2018 Apr 09; 41(4):739-747. PubMed ID: 29367427
    [Abstract] [Full Text] [Related]

  • 4. Soluble Tumor Necrosis Factor Receptor Type 1 Levels Exhibit A Stronger Association With Renal Outcomes Than Traditional Risk Factors in Chinese Subjects With Type 2 Diabetes Mellitus.
    Chang LH, Hwu CM, Lin YC, Huang CC, Won JGS, Chen HS, Lin LY.
    Endocr Pract; 2020 Oct 09; 26(10):1115-1124. PubMed ID: 33471713
    [Abstract] [Full Text] [Related]

  • 5. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
    Satirapoj B, Dispan R, Radinahamed P, Kitiyakara C.
    BMC Nephrol; 2018 Sep 21; 19(1):246. PubMed ID: 30241508
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease.
    Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F, Di Mauro S, Filippello A, Scamporrino A, Tribulato P, Bosco G, Di Giacomo Barbagallo F, Scicali R, Milluzzo A, Ballirò T, Frittitta L, Castellino P, Purrello F, Piro S, Di Pino A.
    Cardiovasc Diabetol; 2023 Dec 13; 22(1):344. PubMed ID: 38093293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective Cohort.
    Saulnier PJ, Gand E, Velho G, Mohammedi K, Zaoui P, Fraty M, Halimi JM, Roussel R, Ragot S, Hadjadj S, SURDIAGENE Study Group.
    Diabetes Care; 2017 Mar 13; 40(3):367-374. PubMed ID: 27998909
    [Abstract] [Full Text] [Related]

  • 11. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug 13; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ.
    BMC Nephrol; 2020 May 07; 21(1):167. PubMed ID: 32380961
    [Abstract] [Full Text] [Related]

  • 14. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS, Wan EY, Chan AK, Lam CL.
    BMC Nephrol; 2017 Feb 02; 18(1):47. PubMed ID: 28152985
    [Abstract] [Full Text] [Related]

  • 15. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K.
    Am J Nephrol; 2018 Feb 02; 47(5):283-291. PubMed ID: 29779026
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can both normal and mildly abnormal albuminuria and glomerular filtration rate be a danger signal for diabetic peripheral neuropathy in type 2 diabetes mellitus?
    Zhang Y, Jiang Y, Shen X, Yan S.
    Neurol Sci; 2017 Aug 02; 38(8):1381-1390. PubMed ID: 28478497
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.